Ranking · Summer 2026 · Healthcare

RonanRx Inc.

Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s

5.2%

odds of being acquired in the next two years

0.8× the average (6.8%)

#3337 of 4,339 active YC companies · top 78%

Team of 5 · San Francisco, CA, USA

Raises the odds

↑ team of 3–5

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

Lowers the odds

↓ under 1.5 years since YC

↓ industry: Healthcare

↓ new to the directory in the last six months

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads RonanRx Inc.'s website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

ronanrx.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub